Abdallah Turky

Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies

Hamada S. Abulkhair, Abdallah Turky, Adel Ghiaty et al. · Bioorganic Chemistry · 2020 · 51 citations

Combinatorial Chemistry, Medicinal Chemistry, Potential Pcaf Inhibitors +9

Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies

Abdallah Turky, Ashraf H. Bayoumi, Farag F. Sherbiny et al. · Molecular Diversity · 2020 · 51 citations

Anticancer Potency, Combinatorial Chemistry, Medicinal Chemistry +9

Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects

Abdallah Turky, Ashraf H. Bayoumi, Adel Ghiaty et al. · Bioorganic Chemistry · 2020 · 47 citations

Medicinal Chemistry, 1,2,4-Triazolophthalazine Scaffold, Antitumor Activity +9

Discovery of new 1 <i>H</i> -pyrazolo[3,4- <i>d</i> ]pyrimidine derivatives as anticancer agents targeting EGFR ^WT and EGFR ^T790M

Ahmed A. Abdel Gaber, Mohamed Sobhy, Abdallah Turky et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 39 citations · Full text

Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies

Abdallah Turky, Farag F. Sherbiny, Ashraf H. Bayoumi et al. · Archiv der Pharmazie · 2020 · 38 citations